Clinical Trial Update: Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vortioxetine for depression associated with radiation injuries in patients with head and neck cancer undergoing radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Major Depressive Disorder
• Radiation Injuries

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Radiation Injuries | Phase 3 | Status: UNKNOWN